Why the study?
It is not understood whether CRT implantation during hospitalization for HF is associated with benefits similar to those seen in ambulatory settings.
Does cardiac resynchronization therapy (CRT) implantation during hospitalization for heart failure reduce mortality and HF re-hospitalization in CRT-eligible patients?
Does cardiac resynchronization therapy (CRT) implantation during hospitalization for heart failure reduce mortality and HF re-hospitalization in CRT-eligible patients?
Implanting a CRT device during a heart failure hospitalization, rather than delaying to the post-discharge period, is associated with reduced mortality and heart failure re-hospitalization.
No takes yet. Share an insight, caveat, or question.
Should not yet change practice for in-hospital CRT; leaves open need for randomized confirmation.
Goldstein et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: